These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35725354)

  • 1. [Applications of the NDR and DIAL models for risk prediction on cardiovascular disease in patients with type 2 diabetes in Ningbo].
    Li QQ; Liang JY; Wang JM; Shen P; Sun YX; Chen Q; Wu JG; Lu P; Zhang JY; Lin HB; Tang X; Gao P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jun; 43(6):945-952. PubMed ID: 35725354
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation and comparison of cardiovascular risk prediction equations in Chinese patients with Type 2 diabetes.
    Liang J; Li Q; Fu Z; Liu X; Shen P; Sun Y; Zhang J; Lu P; Lin H; Tang X; Gao P
    Eur J Prev Cardiol; 2023 Sep; 30(12):1293-1303. PubMed ID: 37315163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2).
    Østergaard HB; Hageman SHJ; Read SH; Taylor O; Pennells L; Kaptoge S; Petitjean C; Xu Z; Shi F; McEvoy JW; Herrington W; Visseren FLJ; Wood A; Eliasson B; Sattar N; Wild S; Di Angelantonio E; Dorresteijn JAN
    Eur J Prev Cardiol; 2023 Jan; 30(1):61-69. PubMed ID: 36208182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of the China-PAR risk prediction model for atherosclerotic cardiovascular disease in a rural northern Chinese population].
    Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Huang SP; Dou HD; Gao P; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):439-445. PubMed ID: 28628144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
    Helmink MAG; Hageman SHJ; Eliasson B; Sattar N; Visseren FLJ; Dorresteijn JAN; Harris K; Peters SAE; Woodward M; Szentkúti P; Højlund K; Henriksen JE; Sørensen HT; Serné EH; van Sloten TT; Thomsen RW; Westerink J
    Diabetes Obes Metab; 2024 Jun; 26(6):2229-2238. PubMed ID: 38456579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of the China-PAR stroke risk equations in a rural northern Chinese population].
    Tang X; Zhang DD; Liu XF; Liu QP; Cao Y; Li N; Huang SP; Dou HD; Gao P; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 52(3):444-450. PubMed ID: 32541976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register.
    Read SH; van Diepen M; Colhoun HM; Halbesma N; Lindsay RS; McKnight JA; McAllister DA; Pearson ER; Petrie JR; Philip S; Sattar N; Woodward M; Wild SH;
    Diabetes Care; 2018 Sep; 41(9):2010-2018. PubMed ID: 30002197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus.
    van der Leeuw J; van Dieren S; Beulens JW; Boeing H; Spijkerman AM; van der Graaf Y; van der A DL; Nöthlings U; Visseren FL; Rutten GE; Moons KG; van der Schouw YT; Peelen LM
    Heart; 2015 Feb; 101(3):222-9. PubMed ID: 25256148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Accuracy of the China-PAR and WHO risk models in predicting the ten-year risks of cardiovascular disease in the Chinese population].
    Chen WY; Liu XF; Shen P; Chen Q; Sun YX; Wu JG; Lu P; Zhang JY; Lin HB; Tang X; Gao P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Aug; 43(8):1275-1281. PubMed ID: 35981990
    [No Abstract]   [Full Text] [Related]  

  • 10. External Validation of a Tool Predicting 7-Year Risk of Developing Cardiovascular Disease, Type 2 Diabetes or Chronic Kidney Disease.
    Rauh SP; Rutters F; van der Heijden AAWA; Luimes T; Alssema M; Heymans MW; Magliano DJ; Shaw JE; Beulens JW; Dekker JM
    J Gen Intern Med; 2018 Feb; 33(2):182-188. PubMed ID: 29204973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK.
    Wan C; Read S; Wu H; Lu S; Zhang X; Wild SH; Liu Y
    Glob Heart; 2022; 17(1):46. PubMed ID: 36051323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of China-PAR and Framingham risk score in assessment of 10-year cardiovascular disease risk in Chinese hypertensive patients.
    Chen X; Tu Q; Wang D; Liu J; Qin Y; Zhang Y; Xiang Q
    Public Health; 2023 Jul; 220():127-134. PubMed ID: 37315498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program.
    Osborn DP; Hardoon S; Omar RZ; Holt RI; King M; Larsen J; Marston L; Morris RW; Nazareth I; Walters K; Petersen I
    JAMA Psychiatry; 2015 Feb; 72(2):143-51. PubMed ID: 25536289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of 10-year risk prediction models of cardiovascular disease in Chinese type 2 diabetes mellitus patients in primary care using interpretable machine learning-based methods.
    Dong W; Wan EYF; Fong DYT; Tan KC; Tsui WW; Hui EM; Chan KH; Fung CSC; Lam CLK
    Diabetes Obes Metab; 2024 Sep; 26(9):3969-3987. PubMed ID: 39010291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
    Xu S; Coleman RL; Wan Q; Gu Y; Meng G; Song K; Shi Z; Xie Q; Tuomilehto J; Holman RR; Niu K; Tong N
    Cardiovasc Diabetol; 2022 Sep; 21(1):182. PubMed ID: 36100925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR).
    Zethelius B; Eliasson B; Eeg-Olofsson K; Svensson AM; Gudbjörnsdottir S; Cederholm J;
    Diabetes Res Clin Pract; 2011 Aug; 93(2):276-284. PubMed ID: 21719139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes.
    van Dieren S; Peelen LM; Nöthlings U; van der Schouw YT; Rutten GE; Spijkerman AM; van der A DL; Sluik D; Boeing H; Moons KG; Beulens JW
    Diabetologia; 2011 Feb; 54(2):264-70. PubMed ID: 21076956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
    [No Abstract]   [Full Text] [Related]  

  • 19. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.
    SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration
    Eur Heart J; 2023 Jul; 44(28):2544-2556. PubMed ID: 37247330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
    Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
    Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.